Evaluation of frozen-section analysis of surgical margins in the treatment of breast cancer

Objective: To evaluate surgical margins in cases of ductal carcinoma through a histopathological exam using frozen sections. Materials and Methods: Retrospective study encompassing 242 conservative surgeries, 179 of which included intraoperative frozensection histopathology and 63 intraoperative nonfreezing techniques (macroscopy/gross examination and cytology). The results of such analyses were compared with those of the histology processing following paraffin embedment and hematoxylin and eosin (H & E) staining. A margin was deemed free when the distance between the tumor and the surgical border was equal to or greater than two millimeters. The factors given consideration for possibly affecting the results were: age, surgical aspects (skin removal and widening of surgical margins), histopathological findings (size, affected lymph nodes, and angiolymphatic invasion), and extensive intraductal and immunohistochemical components (estrogen, progesterone, Ki-67, and HER-2 receptors). In the statistical analyses, the chi-square test was used and negative predictive values were calculated. Results: The negative predictive values were 87.1% and 79.3% for frozen and nonfrozen sections, respectively. There was no significant difference between the two groups (p = 0.14). The factors under consideration had no influence on the results of the intraoperative exam of the margins. Conclusion: The present study allowed to conclude that the intraoperative exam of the surgical margins by frozen section is not superior to a macroscopy and / or cytology exam.

Breast cancer; Conservative surgery; Intraoperative analysis of margins; Freezing of margins

[1] Morrow M.: “Breast conservation and negative margins: how much is enough?”. The Breast, 2009, 18, S84.

[2] Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A. et al.: “Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer”. N. Engl. J. Med., 2002, 347, 1227.

[3] Fisher B., Anderson S., Bryant J., Margolese R., Deutsch M., Fisher E. et al.: “Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer”. N. Engl. J. Med., 2002, 347, 1233.

[4] Wapnir I., Anderson S., Mamounas E., Geyer C., Jeong J.H., tan-Chiu E. et al.: “Prognosis after ipsilateral breast tumor recurrence and local regional recurrence in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials”. J. Clin. Oncol., 2006, 24, 2028.

[5] DiBiase S.J., Komarnicky L.T., Schwartz G.F., Xie Y., Mansfield C.M.: “The number of positive margins influences the outcome of women treated with breast preservation for early-stage breast carcinoma”. Cancer, 1998, 82, 2212.

[6] Gage I., Schnitt S.J., Nixon A.J., Silver B., Recht A., Troyan S.L. et al.: “Pathologic margin involvement and risk of recurrence in patients treated with breast-conserving therapy”. Cancer, 1996; 78, 1921.

[7] Cowen D., Houvenaehel G., Bardou V., Jacquemier J., Bautrant E., Conte M. et al.: “Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer”. Int. J. Radiat. Oncol. Biol. Phys., 2000, 47, 305.

[8] Schnitt S.J., Abner A., Gelman R., Connolly J.L., Recht A., Duda R.B. et al.: “The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy”. Cancer, 1994, 74, 1746.

[9] Wazer D.E., Jacro G., Ruthazer R., Schmid C., Safaii H., Schmidt-Ullrich R.K. et al.: “Extent of margin positivity as a predictor for local recurrence after breast-conserving irradiation”. Radiat. Oncol. Invest., 1999, 7, 111.

[10] Park C.C, Mitsumori M, Nixon A, Recht A,Connolly J, Gelman R et al.: “Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence”. J. Clin. Oncol. 2000, 18, 1668.

[11] Peterson M.E., Schultz D.J., Reynolds C., Solin L.J.: “Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience”. Int. J. Radiat. Oncol. Biol. Phys., 1999, 43, 1029.

[12] Dillon M.F., Hill A.D.K., Quinn C.M., McDermott E.W., O’Higgins N.: “A pathologic assessment of adequate margin status in breast-conserving therapy”. Ann. Surg. Oncol., 2006, 13, 333.

[13] Creager A.J., Shaw J.A., Young P.R., Geisinger K.R.: “Intraoperative evaluation of lumpectomy margins by imprint cytology with histologic correlation: a community hospital experience”. Arch. Pathol. Lab. Med., 2002, 126, 846.

[14] Klimberg V.S., Harms S., Korourian S.: “Assessing margin status”. Surg. Oncol., 1999, 2, 77.

[15] Riedl O., Fitzal F., Mader N., Dubsky P., Rudas M., Mittlboeck M. et al.: “Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer”. Eur. J. Surg. Oncol., 2009, 35, 264.

[16] Weber S., Storm F.K., Stitt J., Mahvi D.M.: “The role of frozen section analysis of margins during breast conservation surgery”. Cancer J. Sci. Am., 1997, 3, 273.

[17] Pinotti J.A., Carvalho F.M.: “Intraoperative pathological monitorization of surgical margins: a method to reduce recurrences after conservative treatment for breast cancer”. Eur. J. Gynaecol. Oncol., 2002, 23, 11.

[18] Fernandes R.C., Bevilacqua J.L., Soares I.C., Siqueira S.A., Pires L., Hegg R., Carvalho F.M.: “Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas”. Histopathology, 2009, 55, 346.

[19] Ellis I., Schnitt S.J., Sastre-Garau X., Bussolati G., Tavassoli F.A., Eusebi V. et al. In: Tavassoli F.A., Devilee P. (eds.). World Health Organization Classification of Tumours. Pathology & Genetics -Tumours of the breast and female genital organs. Lyon, IARC Press, 2003, 9.

[20] Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. (eds.). AJCC Cancer Staging Manual, 7th edition. s.l., New York, Springer, 2010.

[21] Lovrics P., Cornacchi S., Farrokhyar F., Garnett A., Chen V., Franic S.: “The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer”. Am. J. Surg., 2009, 197, 740.

[22] Nielsen T.O., Hsu F.D., Jensen K., Cheang M., Karaca G., Hu Z., Hernandez-Boussard T. et al.: “Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma”. Clin. Cancer Res., 2004, 16, 5367.

[23] Rosner B.: “Fundaments of Biostatistics”. 2nd Edition. Boston, PWS Publishers, 1986, 584.

[24] Fletcher R.H., Fletcher S.W., Wagner E.H.: “Epidemiologia Clínica: Elementos Essenciais”. 3a. edição. São Paulo, Editora Artmed, 2002, 281.

[25] Newman L.A., Kuerer H.M.: “Advances in breast conservation therapy”. J. Clin. Oncol., 2005, 23, 1685.

[26] von Smitten K.: “Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?”. J. Surg. Oncol., 2008, 98, 585.

[27] Luini A., Rososchansky J., Gatti G., Zurrida S., Caldarella P., Viale G. et al: “The surgical margin status aftre breast-conserving surgery: discussion of an open issue”. Breast Cancer Res. Treat., 2009, 113, 397.

[28] Olson T.P., Harter J., Muñoz A., Mahvi D.M., Breslin T.M.: “Frozen section analysis for intraoperativemargin assessment during breast conserving surgery results in low rates of re-excision and local recurrence”. Ann. Surg. Oncol., 2007, 14, 2953.

[29] Cendán J.C., Coco D., Copeland E.M. 3rd: “Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins”. J. Am. Coll. Surg., 2005, 201, 194.

[30] Weber W.P., Engelberger S., Viehl C.T., Zanetti-Dallenbach R., Kuster S., Dirnhofer S. et al.: “Accuracy of frozen section analysis versus specimen radography during breast-conserving surgery for nonpalpable lesions”. World J. Surg., 2008, 32, 2599.

[31] Moore M.M., Borossa G., Imbrie J.Z., Fechner R.E., Harvey J.A., Slingluff C.L. Jr. et al.: “Association of infiltrating lobular carcinoma with positive surgical margins after breast consevation therapy: results of a survey”. Ann. Surg., 2000, 231, 877.